AKT2 and Hashimoto thyroiditis: Larson found that PI3K pathway - the key pathway of tumor progression especially in phosphorylated Akt, Akt1 and Akt2, was expressed in thyroid cancer and Hashimoto’s thyroiditis, but not in normal thyroid tissues (30).